{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-21-056340","form_type":"8-K","ticker":"FZMD","cik":"0000319016","company_name":"Fuse Medical, Inc.","filed_at":"2021-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:04:15.063438+00:00","generated_at":"2026-06-28T09:33:27.324500+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Fuse Medical obtains waiver of EBITDA default; loan limit cut to $2.55M, term extended to Feb 2022","bullets":["Lender waived default for failing to meet $600K minimum EBITDA for trailing twelve months ended Sep 30, 2021.","Aggregate loan limit reduced to $2,550,000 from prior level.","Termination date extended to February 4, 2022; interest rate Prime + 1.00%.","President/Chairman Mark Brooks’ annual salary capped at $550,000 as part of amendment.","Company and guarantors released all claims against lender."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-21-056340","json":"https://secwatch.observer/filing/0001564590-21-056340.json","markdown":"https://secwatch.observer/filing/0001564590-21-056340.md","text":"https://secwatch.observer/filing/0001564590-21-056340.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/319016/000156459021056340/0001564590-21-056340-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/319016/000156459021056340/fzmd-8k_20211110.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T09:33:27.324500+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}